<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2984705R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2786</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Res.</journal-id>
<journal-title-group>
<journal-title>Cancer research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0008-5472</issn>
<issn pub-type="epub">1538-7445</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27815386</article-id>
<article-id pub-id-type="pmc">5214974</article-id>
<article-id pub-id-type="doi">10.1158/0008-5472.CAN-16-1991</article-id>
<article-id pub-id-type="manuscript">NIHMS828639</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>PTEN signaling in the postnatal perivascular progenitor niche drives medulloblastoma formation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Guo</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rankin</surname>
<given-names>Sherri L</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larson</surname>
<given-names>Jon D</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Xiaoyan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chow</surname>
<given-names>Lionel ML</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qu</surname>
<given-names>Chunxu</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jinghui</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ellison</surname>
<given-names>David W</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Suzanne J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Developmental Neurobiology, St. Jude Children’s Research Hospital</aff>
<aff id="A2"><label>2</label>Integrated Program in Biomedical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA</aff>
<aff id="A3"><label>3</label>Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229</aff>
<aff id="A4"><label>4</label>Department of Computational Biology, St. Jude Children’s Research Hospital</aff>
<aff id="A5"><label>5</label>Department of Pathology, St. Jude Children’s Research Hospital</aff>
<author-notes>
<corresp id="FN1">To whom correspondence should be addressed: <email>Suzanne.Baker@stjude.org</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>The authors declare no potential conflicts of interest</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>77</volume>
<issue>1</issue>
<fpage>123</fpage>
<lpage>133</lpage>
<!--elocation-id from pubmed: 10.1158/0008-5472.CAN-16-1991-->
<abstract>
<p id="P1">Loss of the tumor suppressor gene <italic>PTEN</italic> exerts diverse outcomes on cancer in different developmental contexts. To gain insight into the effect of its loss on outcomes in the brain, we conditionally inactivated the murine <italic>Pten</italic> gene in neonatal neural stem/progenitor cells. <italic>Pten</italic> inactivation created an abnormal perivascular proliferative niche in the cerebellum that persisted in adult animals but did not progress to malignancy. Proliferating cells showed undifferentiated morphology and expressed the progenitor marker Nestin but not Math1, a marker of committed granule neuron progenitors. Co-deletion of <italic>Pten</italic> and <italic>Trp53</italic> resulted in fully penetrant medulloblastoma originating from the perivascular niche, which exhibited abnormal blood vessel networks and advanced neuronal differentiation of tumor cells. EdU pulse-chase experiments demonstrated a perivascular cancer stem cell population in <italic>Pten/Trp53</italic> double mutant medulloblastomas. Genetic analyses revealed recurrent somatic inactivations of the tumor suppressor gene <italic>Ptch1</italic> and a recapitulation of the sonic hedgehog subgroup of human medulloblastomas. Overall, our results showed that PTEN acts to prevent proliferation of a progenitor niche in postnatal cerebellum predisposed to oncogenic induction of medulloblastoma.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>